nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—ADRA2A—type 2 diabetes mellitus	0.257	0.59	CbGaD
Tizanidine—CYP1A2—type 2 diabetes mellitus	0.179	0.41	CbGaD
Tizanidine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0855	0.271	CbGbCtD
Tizanidine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0811	0.257	CbGbCtD
Tizanidine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0564	0.179	CbGbCtD
Tizanidine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0306	0.0968	CbGbCtD
Tizanidine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0241	0.0762	CbGbCtD
Tizanidine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0228	0.0721	CbGbCtD
Tizanidine—CYP1A2—Losartan—type 2 diabetes mellitus	0.0155	0.0491	CbGbCtD
Tizanidine—Brimonidine—ADRA2A—type 2 diabetes mellitus	0.00116	0.35	CrCbGaD
Tizanidine—Apraclonidine—ADRA2A—type 2 diabetes mellitus	0.00104	0.312	CrCbGaD
Tizanidine—Clonidine—ADRA2A—type 2 diabetes mellitus	0.00052	0.157	CrCbGaD
Tizanidine—NISCH—islet of Langerhans—type 2 diabetes mellitus	0.000492	0.12	CbGeAlD
Tizanidine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000475	0.116	CbGeAlD
Tizanidine—NISCH—nephron tubule—type 2 diabetes mellitus	0.000396	0.0964	CbGeAlD
Tizanidine—Clonidine—CYP1A2—type 2 diabetes mellitus	0.000361	0.109	CrCbGaD
Tizanidine—NISCH—pancreas—type 2 diabetes mellitus	0.000346	0.0842	CbGeAlD
Tizanidine—NISCH—cortex of kidney—type 2 diabetes mellitus	0.000339	0.0825	CbGeAlD
Tizanidine—NISCH—adipose tissue—type 2 diabetes mellitus	0.000314	0.0763	CbGeAlD
Tizanidine—Clonidine—CYP3A4—type 2 diabetes mellitus	0.000239	0.072	CrCbGaD
Tizanidine—NISCH—liver—type 2 diabetes mellitus	0.00022	0.0535	CbGeAlD
Tizanidine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000181	0.044	CbGeAlD
Tizanidine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000179	0.0436	CbGeAlD
Tizanidine—ADRA2C—kidney—type 2 diabetes mellitus	0.000159	0.0387	CbGeAlD
Tizanidine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000158	0.0384	CbGeAlD
Tizanidine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000155	0.0377	CbGeAlD
Tizanidine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000143	0.0349	CbGeAlD
Tizanidine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000126	0.0307	CbGeAlD
Tizanidine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000123	0.0301	CbGeAlD
Tizanidine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000114	0.0278	CbGeAlD
Tizanidine—ADRA2C—liver—type 2 diabetes mellitus	0.0001	0.0245	CbGeAlD
Tizanidine—CYP1A2—liver—type 2 diabetes mellitus	8.72e-05	0.0212	CbGeAlD
Tizanidine—Muscle spasms—Losartan—type 2 diabetes mellitus	8.65e-05	0.000477	CcSEcCtD
Tizanidine—Asthenia—Bromocriptine—type 2 diabetes mellitus	8.63e-05	0.000476	CcSEcCtD
Tizanidine—Malaise—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.000475	CcSEcCtD
Tizanidine—Vertigo—Irbesartan—type 2 diabetes mellitus	8.59e-05	0.000474	CcSEcCtD
Tizanidine—Syncope—Irbesartan—type 2 diabetes mellitus	8.57e-05	0.000473	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	8.56e-05	0.000472	CcSEcCtD
Tizanidine—Leukopenia—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000472	CcSEcCtD
Tizanidine—Discomfort—Metformin—type 2 diabetes mellitus	8.52e-05	0.00047	CcSEcCtD
Tizanidine—Fatigue—Gliclazide—type 2 diabetes mellitus	8.52e-05	0.00047	CcSEcCtD
Tizanidine—Nausea—Glipizide—type 2 diabetes mellitus	8.49e-05	0.000468	CcSEcCtD
Tizanidine—Vomiting—Glimepiride—type 2 diabetes mellitus	8.48e-05	0.000468	CcSEcCtD
Tizanidine—Hypotension—Valsartan—type 2 diabetes mellitus	8.48e-05	0.000468	CcSEcCtD
Tizanidine—Vision blurred—Losartan—type 2 diabetes mellitus	8.48e-05	0.000468	CcSEcCtD
Tizanidine—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.45e-05	0.000466	CcSEcCtD
Tizanidine—Constipation—Gliclazide—type 2 diabetes mellitus	8.45e-05	0.000466	CcSEcCtD
Tizanidine—Tremor—Losartan—type 2 diabetes mellitus	8.43e-05	0.000465	CcSEcCtD
Tizanidine—Rash—Glimepiride—type 2 diabetes mellitus	8.41e-05	0.000464	CcSEcCtD
Tizanidine—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.4e-05	0.000464	CcSEcCtD
Tizanidine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.000463	CcSEcCtD
Tizanidine—Rash—Sitagliptin—type 2 diabetes mellitus	8.38e-05	0.000463	CcSEcCtD
Tizanidine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.38e-05	0.000462	CcSEcCtD
Tizanidine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000462	CcSEcCtD
Tizanidine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	8.34e-05	0.00046	CcSEcCtD
Tizanidine—Anaemia—Losartan—type 2 diabetes mellitus	8.31e-05	0.000459	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	8.27e-05	0.000456	CcSEcCtD
Tizanidine—Agitation—Losartan—type 2 diabetes mellitus	8.26e-05	0.000456	CcSEcCtD
Tizanidine—Oedema—Metformin—type 2 diabetes mellitus	8.26e-05	0.000456	CcSEcCtD
Tizanidine—Tinnitus—Ramipril—type 2 diabetes mellitus	8.26e-05	0.000456	CcSEcCtD
Tizanidine—Hypertension—Irbesartan—type 2 diabetes mellitus	8.25e-05	0.000455	CcSEcCtD
Tizanidine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.23e-05	0.000454	CcSEcCtD
Tizanidine—Infection—Metformin—type 2 diabetes mellitus	8.21e-05	0.000453	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	8.17e-05	0.000451	CcSEcCtD
Tizanidine—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.15e-05	0.00045	CcSEcCtD
Tizanidine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.14e-05	0.000449	CcSEcCtD
Tizanidine—Arthralgia—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000449	CcSEcCtD
Tizanidine—Shock—Metformin—type 2 diabetes mellitus	8.13e-05	0.000449	CcSEcCtD
Tizanidine—Malaise—Losartan—type 2 diabetes mellitus	8.11e-05	0.000447	CcSEcCtD
Tizanidine—Anxiety—Irbesartan—type 2 diabetes mellitus	8.11e-05	0.000447	CcSEcCtD
Tizanidine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.11e-05	0.000447	CcSEcCtD
Tizanidine—Nervous system disorder—Metformin—type 2 diabetes mellitus	8.11e-05	0.000447	CcSEcCtD
Tizanidine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.09e-05	0.000446	CcSEcCtD
Tizanidine—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.09e-05	0.000446	CcSEcCtD
Tizanidine—Vertigo—Losartan—type 2 diabetes mellitus	8.08e-05	0.000446	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	8.08e-05	0.000446	CcSEcCtD
Tizanidine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.08e-05	0.000446	CcSEcCtD
Tizanidine—Somnolence—Valsartan—type 2 diabetes mellitus	8.07e-05	0.000445	CcSEcCtD
Tizanidine—Syncope—Losartan—type 2 diabetes mellitus	8.07e-05	0.000445	CcSEcCtD
Tizanidine—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.05e-05	0.000444	CcSEcCtD
Tizanidine—Leukopenia—Losartan—type 2 diabetes mellitus	8.05e-05	0.000444	CcSEcCtD
Tizanidine—Discomfort—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000443	CcSEcCtD
Tizanidine—Skin disorder—Metformin—type 2 diabetes mellitus	8.03e-05	0.000443	CcSEcCtD
Tizanidine—Immune system disorder—Ramipril—type 2 diabetes mellitus	8e-05	0.000441	CcSEcCtD
Tizanidine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.99e-05	0.000441	CcSEcCtD
Tizanidine—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.99e-05	0.000441	CcSEcCtD
Tizanidine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.98e-05	0.00044	CcSEcCtD
Tizanidine—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.96e-05	0.000439	CcSEcCtD
Tizanidine—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.96e-05	0.000439	CcSEcCtD
Tizanidine—Nausea—Glimepiride—type 2 diabetes mellitus	7.92e-05	0.000437	CcSEcCtD
Tizanidine—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000437	CcSEcCtD
Tizanidine—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.9e-05	0.000436	CcSEcCtD
Tizanidine—Nausea—Sitagliptin—type 2 diabetes mellitus	7.9e-05	0.000436	CcSEcCtD
Tizanidine—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.89e-05	0.000435	CcSEcCtD
Tizanidine—Asthenia—Glyburide—type 2 diabetes mellitus	7.89e-05	0.000435	CcSEcCtD
Tizanidine—Urticaria—Gliclazide—type 2 diabetes mellitus	7.85e-05	0.000433	CcSEcCtD
Tizanidine—Alopecia—Ramipril—type 2 diabetes mellitus	7.83e-05	0.000432	CcSEcCtD
Tizanidine—Fatigue—Valsartan—type 2 diabetes mellitus	7.82e-05	0.000432	CcSEcCtD
Tizanidine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.81e-05	0.000431	CcSEcCtD
Tizanidine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.81e-05	0.000431	CcSEcCtD
Tizanidine—Oedema—Irbesartan—type 2 diabetes mellitus	7.8e-05	0.00043	CcSEcCtD
Tizanidine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.8e-05	0.00043	CcSEcCtD
Tizanidine—Pruritus—Glyburide—type 2 diabetes mellitus	7.78e-05	0.000429	CcSEcCtD
Tizanidine—Mental disorder—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000428	CcSEcCtD
Tizanidine—Constipation—Valsartan—type 2 diabetes mellitus	7.76e-05	0.000428	CcSEcCtD
Tizanidine—Infection—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000427	CcSEcCtD
Tizanidine—Fatigue—Orlistat—type 2 diabetes mellitus	7.73e-05	0.000427	CcSEcCtD
Tizanidine—Hypotension—Metformin—type 2 diabetes mellitus	7.72e-05	0.000426	CcSEcCtD
Tizanidine—Shock—Irbesartan—type 2 diabetes mellitus	7.67e-05	0.000423	CcSEcCtD
Tizanidine—Arthralgia—Losartan—type 2 diabetes mellitus	7.66e-05	0.000422	CcSEcCtD
Tizanidine—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.65e-05	0.000422	CcSEcCtD
Tizanidine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000422	CcSEcCtD
Tizanidine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000421	CcSEcCtD
Tizanidine—Anxiety—Losartan—type 2 diabetes mellitus	7.63e-05	0.000421	CcSEcCtD
Tizanidine—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.00042	CcSEcCtD
Tizanidine—Rash—Bromocriptine—type 2 diabetes mellitus	7.59e-05	0.000419	CcSEcCtD
Tizanidine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.58e-05	0.000418	CcSEcCtD
Tizanidine—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.000418	CcSEcCtD
Tizanidine—Tension—Ramipril—type 2 diabetes mellitus	7.57e-05	0.000417	CcSEcCtD
Tizanidine—Discomfort—Losartan—type 2 diabetes mellitus	7.57e-05	0.000417	CcSEcCtD
Tizanidine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000416	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.53e-05	0.000415	CcSEcCtD
Tizanidine—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.53e-05	0.000415	CcSEcCtD
Tizanidine—Nervousness—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000413	CcSEcCtD
Tizanidine—Dry mouth—Losartan—type 2 diabetes mellitus	7.49e-05	0.000413	CcSEcCtD
Tizanidine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000409	CcSEcCtD
Tizanidine—Paraesthesia—Metformin—type 2 diabetes mellitus	7.42e-05	0.000409	CcSEcCtD
Tizanidine—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000409	CcSEcCtD
Tizanidine—Confusional state—Losartan—type 2 diabetes mellitus	7.4e-05	0.000408	CcSEcCtD
Tizanidine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.39e-05	0.000408	CcSEcCtD
Tizanidine—Dyspnoea—Metformin—type 2 diabetes mellitus	7.37e-05	0.000406	CcSEcCtD
Tizanidine—Somnolence—Metformin—type 2 diabetes mellitus	7.35e-05	0.000405	CcSEcCtD
Tizanidine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.34e-05	0.000405	CcSEcCtD
Tizanidine—Oedema—Losartan—type 2 diabetes mellitus	7.34e-05	0.000405	CcSEcCtD
Tizanidine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.33e-05	0.000405	CcSEcCtD
Tizanidine—Infection—Losartan—type 2 diabetes mellitus	7.29e-05	0.000402	CcSEcCtD
Tizanidine—Hypotension—Irbesartan—type 2 diabetes mellitus	7.29e-05	0.000402	CcSEcCtD
Tizanidine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.28e-05	0.000401	CcSEcCtD
Tizanidine—Dyspepsia—Metformin—type 2 diabetes mellitus	7.28e-05	0.000401	CcSEcCtD
Tizanidine—Tremor—Ramipril—type 2 diabetes mellitus	7.23e-05	0.000399	CcSEcCtD
Tizanidine—Shock—Losartan—type 2 diabetes mellitus	7.22e-05	0.000398	CcSEcCtD
Tizanidine—Urticaria—Valsartan—type 2 diabetes mellitus	7.21e-05	0.000398	CcSEcCtD
Tizanidine—Nervous system disorder—Losartan—type 2 diabetes mellitus	7.2e-05	0.000397	CcSEcCtD
Tizanidine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.19e-05	0.000396	CcSEcCtD
Tizanidine—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.17e-05	0.000396	CcSEcCtD
Tizanidine—Tachycardia—Losartan—type 2 diabetes mellitus	7.16e-05	0.000395	CcSEcCtD
Tizanidine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000395	CcSEcCtD
Tizanidine—Nausea—Bromocriptine—type 2 diabetes mellitus	7.15e-05	0.000394	CcSEcCtD
Tizanidine—Fatigue—Metformin—type 2 diabetes mellitus	7.13e-05	0.000393	CcSEcCtD
Tizanidine—Urticaria—Orlistat—type 2 diabetes mellitus	7.12e-05	0.000393	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000392	CcSEcCtD
Tizanidine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.1e-05	0.000391	CcSEcCtD
Tizanidine—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.09e-05	0.000391	CcSEcCtD
Tizanidine—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.09e-05	0.000391	CcSEcCtD
Tizanidine—Asthenia—Gliclazide—type 2 diabetes mellitus	7.09e-05	0.000391	CcSEcCtD
Tizanidine—Agitation—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000391	CcSEcCtD
Tizanidine—Constipation—Metformin—type 2 diabetes mellitus	7.07e-05	0.00039	CcSEcCtD
Tizanidine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7e-05	0.000386	CcSEcCtD
Tizanidine—Vomiting—Glyburide—type 2 diabetes mellitus	6.99e-05	0.000386	CcSEcCtD
Tizanidine—Pruritus—Gliclazide—type 2 diabetes mellitus	6.99e-05	0.000386	CcSEcCtD
Tizanidine—Malaise—Ramipril—type 2 diabetes mellitus	6.95e-05	0.000384	CcSEcCtD
Tizanidine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.95e-05	0.000384	CcSEcCtD
Tizanidine—Rash—Glyburide—type 2 diabetes mellitus	6.94e-05	0.000383	CcSEcCtD
Tizanidine—Somnolence—Irbesartan—type 2 diabetes mellitus	6.93e-05	0.000382	CcSEcCtD
Tizanidine—Dermatitis—Glyburide—type 2 diabetes mellitus	6.93e-05	0.000382	CcSEcCtD
Tizanidine—Vertigo—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000382	CcSEcCtD
Tizanidine—Syncope—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000381	CcSEcCtD
Tizanidine—Leukopenia—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000381	CcSEcCtD
Tizanidine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000379	CcSEcCtD
Tizanidine—Hypotension—Losartan—type 2 diabetes mellitus	6.86e-05	0.000378	CcSEcCtD
Tizanidine—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.81e-05	0.000376	CcSEcCtD
Tizanidine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000374	CcSEcCtD
Tizanidine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.76e-05	0.000373	CcSEcCtD
Tizanidine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.76e-05	0.000373	CcSEcCtD
Tizanidine—Fatigue—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.000371	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.69e-05	0.000369	CcSEcCtD
Tizanidine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.69e-05	0.000369	CcSEcCtD
Tizanidine—Convulsion—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000369	CcSEcCtD
Tizanidine—Constipation—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.000368	CcSEcCtD
Tizanidine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.61e-05	0.000364	CcSEcCtD
Tizanidine—Paraesthesia—Losartan—type 2 diabetes mellitus	6.59e-05	0.000364	CcSEcCtD
Tizanidine—Urticaria—Metformin—type 2 diabetes mellitus	6.57e-05	0.000362	CcSEcCtD
Tizanidine—Arthralgia—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000362	CcSEcCtD
Tizanidine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.54e-05	0.000361	CcSEcCtD
Tizanidine—Anxiety—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000361	CcSEcCtD
Tizanidine—Nausea—Glyburide—type 2 diabetes mellitus	6.53e-05	0.00036	CcSEcCtD
Tizanidine—Abdominal pain—Metformin—type 2 diabetes mellitus	6.53e-05	0.00036	CcSEcCtD
Tizanidine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.53e-05	0.00036	CcSEcCtD
Tizanidine—Somnolence—Losartan—type 2 diabetes mellitus	6.53e-05	0.00036	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.52e-05	0.00036	CcSEcCtD
Tizanidine—Asthenia—Valsartan—type 2 diabetes mellitus	6.51e-05	0.000359	CcSEcCtD
Tizanidine—Discomfort—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000358	CcSEcCtD
Tizanidine—Dyspepsia—Losartan—type 2 diabetes mellitus	6.46e-05	0.000356	CcSEcCtD
Tizanidine—Asthenia—Orlistat—type 2 diabetes mellitus	6.43e-05	0.000355	CcSEcCtD
Tizanidine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000355	CcSEcCtD
Tizanidine—Pruritus—Valsartan—type 2 diabetes mellitus	6.42e-05	0.000354	CcSEcCtD
Tizanidine—Dry mouth—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000354	CcSEcCtD
Tizanidine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000352	CcSEcCtD
Tizanidine—Confusional state—Ramipril—type 2 diabetes mellitus	6.35e-05	0.00035	CcSEcCtD
Tizanidine—Pruritus—Orlistat—type 2 diabetes mellitus	6.34e-05	0.00035	CcSEcCtD
Tizanidine—Fatigue—Losartan—type 2 diabetes mellitus	6.33e-05	0.000349	CcSEcCtD
Tizanidine—Oedema—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000347	CcSEcCtD
Tizanidine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000347	CcSEcCtD
Tizanidine—Vomiting—Gliclazide—type 2 diabetes mellitus	6.28e-05	0.000346	CcSEcCtD
Tizanidine—Constipation—Losartan—type 2 diabetes mellitus	6.28e-05	0.000346	CcSEcCtD
Tizanidine—Rash—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.000344	CcSEcCtD
Tizanidine—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.22e-05	0.000343	CcSEcCtD
Tizanidine—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.21e-05	0.000343	CcSEcCtD
Tizanidine—Urticaria—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.000342	CcSEcCtD
Tizanidine—Shock—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000342	CcSEcCtD
Tizanidine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.17e-05	0.00034	CcSEcCtD
Tizanidine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.00034	CcSEcCtD
Tizanidine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.00034	CcSEcCtD
Tizanidine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.16e-05	0.00034	CcSEcCtD
Tizanidine—Tachycardia—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000339	CcSEcCtD
Tizanidine—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.14e-05	0.000338	CcSEcCtD
Tizanidine—Skin disorder—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000337	CcSEcCtD
Tizanidine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000336	CcSEcCtD
Tizanidine—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.05e-05	0.000334	CcSEcCtD
Tizanidine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6e-05	0.000331	CcSEcCtD
Tizanidine—Dizziness—Valsartan—type 2 diabetes mellitus	6e-05	0.000331	CcSEcCtD
Tizanidine—Dizziness—Orlistat—type 2 diabetes mellitus	5.93e-05	0.000327	CcSEcCtD
Tizanidine—Asthenia—Metformin—type 2 diabetes mellitus	5.93e-05	0.000327	CcSEcCtD
Tizanidine—Hypotension—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000324	CcSEcCtD
Tizanidine—Nausea—Gliclazide—type 2 diabetes mellitus	5.87e-05	0.000324	CcSEcCtD
Tizanidine—Pruritus—Metformin—type 2 diabetes mellitus	5.85e-05	0.000323	CcSEcCtD
Tizanidine—Urticaria—Losartan—type 2 diabetes mellitus	5.83e-05	0.000322	CcSEcCtD
Tizanidine—Abdominal pain—Losartan—type 2 diabetes mellitus	5.8e-05	0.00032	CcSEcCtD
Tizanidine—Body temperature increased—Losartan—type 2 diabetes mellitus	5.8e-05	0.00032	CcSEcCtD
Tizanidine—Vomiting—Valsartan—type 2 diabetes mellitus	5.77e-05	0.000318	CcSEcCtD
Tizanidine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.75e-05	0.000317	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000316	CcSEcCtD
Tizanidine—Rash—Valsartan—type 2 diabetes mellitus	5.72e-05	0.000316	CcSEcCtD
Tizanidine—Dermatitis—Valsartan—type 2 diabetes mellitus	5.72e-05	0.000315	CcSEcCtD
Tizanidine—Vomiting—Orlistat—type 2 diabetes mellitus	5.7e-05	0.000315	CcSEcCtD
Tizanidine—Diarrhoea—Metformin—type 2 diabetes mellitus	5.65e-05	0.000312	CcSEcCtD
Tizanidine—Rash—Orlistat—type 2 diabetes mellitus	5.65e-05	0.000312	CcSEcCtD
Tizanidine—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.65e-05	0.000312	CcSEcCtD
Tizanidine—Dermatitis—Orlistat—type 2 diabetes mellitus	5.65e-05	0.000312	CcSEcCtD
Tizanidine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.61e-05	0.00031	CcSEcCtD
Tizanidine—Asthenia—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.000309	CcSEcCtD
Tizanidine—Somnolence—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000309	CcSEcCtD
Tizanidine—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000306	CcSEcCtD
Tizanidine—Pruritus—Irbesartan—type 2 diabetes mellitus	5.52e-05	0.000304	CcSEcCtD
Tizanidine—Dizziness—Metformin—type 2 diabetes mellitus	5.47e-05	0.000301	CcSEcCtD
Tizanidine—Fatigue—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000299	CcSEcCtD
Tizanidine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.41e-05	0.000298	CcSEcCtD
Tizanidine—Nausea—Valsartan—type 2 diabetes mellitus	5.39e-05	0.000297	CcSEcCtD
Tizanidine—Constipation—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000297	CcSEcCtD
Tizanidine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.34e-05	0.000294	CcSEcCtD
Tizanidine—Nausea—Orlistat—type 2 diabetes mellitus	5.33e-05	0.000294	CcSEcCtD
Tizanidine—Asthenia—Losartan—type 2 diabetes mellitus	5.27e-05	0.000291	CcSEcCtD
Tizanidine—Vomiting—Metformin—type 2 diabetes mellitus	5.25e-05	0.00029	CcSEcCtD
Tizanidine—Rash—Metformin—type 2 diabetes mellitus	5.21e-05	0.000287	CcSEcCtD
Tizanidine—Dermatitis—Metformin—type 2 diabetes mellitus	5.21e-05	0.000287	CcSEcCtD
Tizanidine—Pruritus—Losartan—type 2 diabetes mellitus	5.19e-05	0.000286	CcSEcCtD
Tizanidine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000286	CcSEcCtD
Tizanidine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000285	CcSEcCtD
Tizanidine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000284	CcSEcCtD
Tizanidine—Diarrhoea—Losartan—type 2 diabetes mellitus	5.02e-05	0.000277	CcSEcCtD
Tizanidine—Urticaria—Ramipril—type 2 diabetes mellitus	5e-05	0.000276	CcSEcCtD
Tizanidine—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000274	CcSEcCtD
Tizanidine—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000274	CcSEcCtD
Tizanidine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000274	CcSEcCtD
Tizanidine—Rash—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000271	CcSEcCtD
Tizanidine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.91e-05	0.000271	CcSEcCtD
Tizanidine—Nausea—Metformin—type 2 diabetes mellitus	4.91e-05	0.000271	CcSEcCtD
Tizanidine—Dizziness—Losartan—type 2 diabetes mellitus	4.85e-05	0.000268	CcSEcCtD
Tizanidine—Vomiting—Losartan—type 2 diabetes mellitus	4.67e-05	0.000257	CcSEcCtD
Tizanidine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000256	CcSEcCtD
Tizanidine—Nausea—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000256	CcSEcCtD
Tizanidine—Rash—Losartan—type 2 diabetes mellitus	4.63e-05	0.000255	CcSEcCtD
Tizanidine—Dermatitis—Losartan—type 2 diabetes mellitus	4.62e-05	0.000255	CcSEcCtD
Tizanidine—Asthenia—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000249	CcSEcCtD
Tizanidine—Pruritus—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000246	CcSEcCtD
Tizanidine—Nausea—Losartan—type 2 diabetes mellitus	4.36e-05	0.000241	CcSEcCtD
Tizanidine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000238	CcSEcCtD
Tizanidine—Dizziness—Ramipril—type 2 diabetes mellitus	4.16e-05	0.00023	CcSEcCtD
Tizanidine—Vomiting—Ramipril—type 2 diabetes mellitus	4e-05	0.000221	CcSEcCtD
Tizanidine—Rash—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000219	CcSEcCtD
Tizanidine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000219	CcSEcCtD
Tizanidine—Nausea—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000206	CcSEcCtD
Tizanidine—ADRA2B—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.91e-06	0.000149	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.87e-06	0.000149	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	8.84e-06	0.000148	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.83e-06	0.000148	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.78e-06	0.000147	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CD36—type 2 diabetes mellitus	8.77e-06	0.000147	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.74e-06	0.000146	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.74e-06	0.000146	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPP2CA—type 2 diabetes mellitus	8.66e-06	0.000145	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOB—type 2 diabetes mellitus	8.65e-06	0.000145	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.63e-06	0.000145	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.62e-06	0.000144	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—SRC—type 2 diabetes mellitus	8.59e-06	0.000144	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.56e-06	0.000143	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	8.54e-06	0.000143	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	8.54e-06	0.000143	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	8.54e-06	0.000143	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	8.54e-06	0.000143	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.52e-06	0.000143	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.48e-06	0.000142	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.39e-06	0.000141	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VEGFA—type 2 diabetes mellitus	8.37e-06	0.00014	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.36e-06	0.00014	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AVP—type 2 diabetes mellitus	8.36e-06	0.00014	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.33e-06	0.00014	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—MTHFR—type 2 diabetes mellitus	8.31e-06	0.000139	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.29e-06	0.000139	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LPL—type 2 diabetes mellitus	8.26e-06	0.000138	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.23e-06	0.000138	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GNB3—type 2 diabetes mellitus	8.23e-06	0.000138	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.21e-06	0.000138	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.2e-06	0.000137	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HMOX1—type 2 diabetes mellitus	8.2e-06	0.000137	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	8.18e-06	0.000137	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARA—type 2 diabetes mellitus	8.15e-06	0.000137	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.13e-06	0.000136	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.09e-06	0.000136	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.09e-06	0.000136	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CAT—type 2 diabetes mellitus	8.09e-06	0.000136	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOB—type 2 diabetes mellitus	8.08e-06	0.000135	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.05e-06	0.000135	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GCG—type 2 diabetes mellitus	7.99e-06	0.000134	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.99e-06	0.000134	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.95e-06	0.000133	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.95e-06	0.000133	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AGT—type 2 diabetes mellitus	7.9e-06	0.000132	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.86e-06	0.000132	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOB—type 2 diabetes mellitus	7.85e-06	0.000132	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.83e-06	0.000131	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.79e-06	0.000131	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CALM1—type 2 diabetes mellitus	7.76e-06	0.00013	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.75e-06	0.00013	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOE—type 2 diabetes mellitus	7.74e-06	0.00013	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LPL—type 2 diabetes mellitus	7.72e-06	0.000129	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.7e-06	0.000129	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TGFB1—type 2 diabetes mellitus	7.68e-06	0.000129	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOA1—type 2 diabetes mellitus	7.65e-06	0.000128	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTM1—type 2 diabetes mellitus	7.64e-06	0.000128	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.61e-06	0.000128	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	7.61e-06	0.000128	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.56e-06	0.000127	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—LPL—type 2 diabetes mellitus	7.5e-06	0.000126	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.48e-06	0.000125	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—C3—type 2 diabetes mellitus	7.44e-06	0.000125	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.35e-06	0.000123	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ADCY5—type 2 diabetes mellitus	7.34e-06	0.000123	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.34e-06	0.000123	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GPX1—type 2 diabetes mellitus	7.31e-06	0.000123	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.24e-06	0.000121	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CD36—type 2 diabetes mellitus	7.12e-06	0.000119	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.11e-06	0.000119	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.1e-06	0.000119	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.1e-06	0.000119	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.08e-06	0.000119	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGT—type 2 diabetes mellitus	7.07e-06	0.000118	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—type 2 diabetes mellitus	7.04e-06	0.000118	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPP2CA—type 2 diabetes mellitus	7.03e-06	0.000118	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	6.96e-06	0.000117	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	6.96e-06	0.000117	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.95e-06	0.000116	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.95e-06	0.000116	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—C3—type 2 diabetes mellitus	6.95e-06	0.000116	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOE—type 2 diabetes mellitus	6.93e-06	0.000116	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LEP—type 2 diabetes mellitus	6.93e-06	0.000116	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.89e-06	0.000115	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.85e-06	0.000115	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	6.83e-06	0.000114	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AVP—type 2 diabetes mellitus	6.79e-06	0.000114	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.79e-06	0.000114	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.79e-06	0.000114	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	6.78e-06	0.000114	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	6.78e-06	0.000114	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	6.78e-06	0.000114	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.76e-06	0.000113	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MTHFR—type 2 diabetes mellitus	6.75e-06	0.000113	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	6.74e-06	0.000113	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—type 2 diabetes mellitus	6.74e-06	0.000113	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.73e-06	0.000113	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.66e-06	0.000112	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.63e-06	0.000111	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARA—type 2 diabetes mellitus	6.62e-06	0.000111	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.62e-06	0.000111	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.61e-06	0.000111	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—INS—type 2 diabetes mellitus	6.61e-06	0.000111	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGT—type 2 diabetes mellitus	6.6e-06	0.000111	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—type 2 diabetes mellitus	6.57e-06	0.00011	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	6.57e-06	0.00011	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	6.54e-06	0.00011	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.54e-06	0.00011	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.53e-06	0.000109	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.49e-06	0.000109	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOE—type 2 diabetes mellitus	6.47e-06	0.000108	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LEP—type 2 diabetes mellitus	6.47e-06	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.46e-06	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	6.41e-06	0.000107	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.4e-06	0.000107	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	6.31e-06	0.000106	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	6.28e-06	0.000105	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	6.27e-06	0.000105	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	6.21e-06	0.000104	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.18e-06	0.000104	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.14e-06	0.000103	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.1e-06	0.000102	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.1e-06	0.000102	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.08e-06	0.000102	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.08e-06	0.000102	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.08e-06	0.000102	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—type 2 diabetes mellitus	6.06e-06	0.000102	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.97e-06	0.0001	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5.92e-06	9.92e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—INS—type 2 diabetes mellitus	5.92e-06	9.92e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.88e-06	9.86e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.84e-06	9.78e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.82e-06	9.76e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—NOS3—type 2 diabetes mellitus	5.8e-06	9.71e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3R1—type 2 diabetes mellitus	5.8e-06	9.71e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5.79e-06	9.7e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.78e-06	9.68e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.77e-06	9.67e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.72e-06	9.59e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.72e-06	9.58e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.69e-06	9.54e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	5.64e-06	9.46e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.56e-06	9.32e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—INS—type 2 diabetes mellitus	5.53e-06	9.26e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.5e-06	9.22e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	5.47e-06	9.17e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.44e-06	9.11e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.43e-06	9.11e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.38e-06	9.02e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.37e-06	9e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	5.37e-06	9e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.36e-06	8.99e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	5.36e-06	8.99e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.35e-06	8.96e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.34e-06	8.95e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	5.34e-06	8.95e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.34e-06	8.94e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.32e-06	8.91e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	5.3e-06	8.88e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.27e-06	8.84e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	5.27e-06	8.84e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.27e-06	8.84e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	5.25e-06	8.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	5.25e-06	8.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.19e-06	8.71e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.19e-06	8.7e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.19e-06	8.7e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.08e-06	8.51e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.96e-06	8.3e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	4.92e-06	8.25e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.88e-06	8.18e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.85e-06	8.12e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.85e-06	8.12e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	4.71e-06	7.89e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	4.71e-06	7.89e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.69e-06	7.86e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	4.56e-06	7.65e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.55e-06	7.62e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.55e-06	7.62e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.53e-06	7.58e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	4.49e-06	7.52e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.46e-06	7.48e-05	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.45e-06	7.45e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.42e-06	7.4e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.41e-06	7.38e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.38e-06	7.33e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.34e-06	7.28e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.34e-06	7.27e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.33e-06	7.26e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.32e-06	7.24e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	4.31e-06	7.22e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.22e-06	7.07e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.16e-06	6.98e-05	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.15e-06	6.96e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.14e-06	6.94e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.12e-06	6.91e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.12e-06	6.9e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.11e-06	6.9e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.09e-06	6.85e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.05e-06	6.79e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.04e-06	6.77e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.04e-06	6.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.94e-06	6.6e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.94e-06	6.6e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.93e-06	6.59e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.89e-06	6.52e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.88e-06	6.51e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.85e-06	6.45e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.84e-06	6.43e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.77e-06	6.32e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.74e-06	6.26e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.73e-06	6.24e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.71e-06	6.21e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.66e-06	6.13e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	3.59e-06	6.01e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.54e-06	5.93e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.49e-06	5.85e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.48e-06	5.83e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.47e-06	5.81e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.43e-06	5.75e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.43e-06	5.75e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.37e-06	5.65e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.36e-06	5.64e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.34e-06	5.6e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.32e-06	5.56e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.2e-06	5.37e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.16e-06	5.29e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.14e-06	5.27e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.13e-06	5.24e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.06e-06	5.13e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.02e-06	5.06e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.96e-06	4.97e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.91e-06	4.88e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.84e-06	4.75e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.72e-06	4.55e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	2.66e-06	4.47e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.6e-06	4.36e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.6e-06	4.36e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.6e-06	4.36e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.59e-06	4.33e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.55e-06	4.28e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	2.42e-06	4.05e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.39e-06	4e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.38e-06	3.98e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.23e-06	3.73e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	2.16e-06	3.63e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.96e-06	3.29e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.81e-06	3.03e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	2e-05	CbGpPWpGaD
